GridAI Technologies (GRDX) Revenue (2026)
GridAI Technologies' (GRDX) quarterly Revenue came in at $85876.0 in Q2 2026.
Powered by 
Analysis
GridAI Technologies (GRDX) Revenue (2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Revenue for 1 consecutive years, with $85876.0 the latest figure, recorded in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.64 Bn | 192.65 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 179.82 Bn | 176.65 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 131.16 Bn | 123.31 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 81.67 Bn | 73.67 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 60.28 Bn | 55.09 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.91 Bn | 48.77 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.12 Bn | 29.81 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 29.05 Bn | 29.05 Bn | 1.16 Mn | 1.44 Mn |
| 10 | GridAI Technologies | 19.39 Mn | 19.39 Mn | -36,514.00 | 85,876.00 |